Page 237 - Mart

haber S ğlık

Timur Veysel Doğruok:
”T-LAB Olarak Dünya Genelinde PRP’YE Yön

Veren Birkaç Firmadan Biri Olarak Gösterildik”

Rejeneratif tıp alanında faaliyet gösteren, Türkiye’nin ilk PRP KİT markası ve üreticisi T-LAB,
Türkiye’deki pazar liderliği başarısını yurt dışında da gerçekleştirmek istiyor. Firma ortakları Timur
Veysel Doğruok ve Salih Özovalı’nın geliştirdiği, hem yurtiçinde hem de yurtdışında en bilinen PRP Kit
markası olan T-LAB, sadece Türkiye değil, dünya genelinde de yaklaşık 40 ülkeye ihracat gerçekleştiriyor.

The Progress of World Regenerative Medical Science

and a Company from Our Country: T-LAB

T-LAB continues to be one of the world’s leading companies in regenerative medicine. T-LAB, which produces
Turkey’s first domestic PRP Kit product and brings it together with physicians in nearly 40 countries around the
world, recently introduced its new product Microlyzer
Microlyzer, which works with adipose tissue, seems to provide superior success in both the cushioning task of fat
tissue as a filling and regeneration treatments. T-LAB’s partners Timur Veysel Doğruok and Salih Özovalı developed
and applied for international patents with cell insulation protocol and microlyzer product; Without any enzyme
requirements, he has managed to exceed the numbers obtained by studies conducted so far.
In in-vitro studies conducted in collaboration with pioneering laboratories in the field, T-LAB found that the mesenchyal
stem cell numbers, which have reached sVF units that have not yet been reached in fresh adipose tissue samples
and have the potential to differentiate, are much more showed a high potential. T-LAB executives, the validation
work of these censuses continued, our country will get the place it deserves in the field of regenerative medicine,
stressed that they are full of faith.
T-LAB also shared its results with expert scientists in this field, and Timur Veysel Doğruok, who assumed the roles
of Founder and General Manager of T-LAB, was invited to the Board of Directors of the International Association
of Stem Cell and Regenerative Medicine.

2020 Mart / 235